CEO, PRESIDENT, AEON BIOPHARMA
WHY: Running latest Alphaeon offshoot, a neurotoxin developer for the treatment of neurological conditions. A former senior vice president of marketing at Allergan, counted 16 years with the pharmaceutical powerhouse.
RECENT: Received a $25M investment from Daewoong Pharmaceutical, the same South Korean pharmaceutical firm that backs and works with Newport Beach-based aesthetics firm Evolus.
QUOTABLE: “We’re most excited about the ability to build a company from scratch in the Newport Beach area,” Forth told Business Journal in September. Team includes talent from Dendreon Pharmaceutical, CoreLogic, Incipio and Edwards Lifesciences.
2020 HOBBY: “My family and I have realized that it is the simple things in life that make us the happiest and have rediscovered our area’s beaches and other natural attractions.”
